Skip to content

A Comparative Study To Evaluate The Effectiveness Of Chakramard Taila And Itraconazole In Treatment Of Fungal Skin Infection

AN OPEN LABELLED RANDOMISED COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF CHAKRAMARDA TAILA AND ITRACONAZOLE IN DADRU With Special Reference TO TINEA - CITI-DAD Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104515
Enrollment
66
Registered
2026-02-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

Vikram Singh Ahirwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either gender between age group of 18 To 60 (both year inclusive). 2. Patients having clinical signs like Kandu, Raga, Mandala, Pidika. 3. Patients of all varieties of Tinea will be included (Tinea-corporis, Crusis, Capitis etc ) 4. Subjects who are willing to give a written consent for the treatment.

Exclusion criteria

Exclusion criteria: 1. Patients having Tinea Unguium, Tinea Barbae. 2. K/C/O Major Systemic Diseases like IHD, Malignancies, Uncontrolled Hypertension and Diabetes Mellitus. 3. Patients with active infective diseases like Tuberculosis, Hepatitis B. 4. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Helps in reducing itchingTimepoint: Total 15 days of treatment will be there. During these 15 days.assessment will be done on 7th and 15th day.

Secondary

MeasureTime frame
To reduce sign & Symptoms of Dadru as follows 1)itching 2)Circular patches 3)Red elevated 4)Burning sensationTimepoint: Total 15 days of treatment will be there. During these 15 days assessment will be done on 7th & 15th day.

Countries

India

Contacts

Public ContactVikram Singh Ahirwar

PG Scholar

vikramsinghahirwar25@gmail.com9893972209

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026